Home › Therapeutic areas › Antihypertensives
Japan market screening · Therapeutic class
血圧降下剤 · Japan Standard Commodity Classification
59 molecules in this class are marketed in Japan across 937 products. 150 of those products are not shipping normally today — 16.0% of the class. Supply status is reported to the Ministry of Health, Labour and Welfare and updated daily.
Ordered by how many products compete. Constrained means limited supply or supply suspended; supply suspended does not mean discontinued.
| Molecule | Products | Companies | Constrained | Supply mix |
|---|---|---|---|---|
| Candesartan Cilexetilカンデサルタンシレキセチル | 76 | 17 | 12 | |
| Valsartanバルサルタン | 68 | 15 | 4 | |
| Olmesartan Medoxomilオルメサルタンメドキソミル | 66 | 14 | 19 | |
| Telmisartanテルミサルタン | 64 | 20 | 9 | |
| Losartan Potassiumロサルタンカリウム | 57 | 19 | 5 | |
| Doxazosin Mesilateドキサゾシンメシル酸塩 | 52 | 12 | 2 | |
| Azilsartanアジルサルタン | 46 | 14 | — | |
| Carvedilolカルベジロール | 40 | 10 | 6 | |
| Enalapril Maleateエナラプリルマレイン酸塩 | 40 | 14 | 7 | |
| Irbesartanイルベサルタン | 36 | 11 | 7 | |
| Losartan Potassium / Hydrochlorothiazideロサルタンカリウム・ヒドロクロロチアジド | 34 | 17 | 7 | |
| Irbesartan / Amlodipine Besilateイルベサルタン・アムロジピンベシル酸塩 | 28 | 14 | 2 | |
| Imidapril Hydrochlorideイミダプリル塩酸塩 | 27 | 9 | 1 | |
| Azilsartan / Amlodipine Besilateアジルサルタン・アムロジピンベシル酸塩 | 24 | 10 | 7 | |
| Azelnidipineアゼルニジピン | 18 | 9 | 6 | |
| Valsartan / Amlodipine Besilateバルサルタン・アムロジピンベシル酸塩 | 17 | 15 | 3 | |
| Nicardipine Hydrochlorideニカルジピン塩酸塩 | 16 | 4 | — | |
| Telmisartan / Amlodipine Besilateテルミサルタン・アムロジピンベシル酸塩 | 16 | 8 | 16 | |
| Valsartan / Hydrochlorothiazideバルサルタン・ヒドロクロロチアジド | 16 | 8 | 4 | |
| Candesartan Cilexetil / Amlodipine Besilateカンデサルタンシレキセチル・アムロジピンベシル酸塩 | 14 | 7 | 1 | |
| Lisinopril Hydrateリシノプリル水和物 | 12 | 4 | — | |
| Manidipine Hydrochlorideマニジピン塩酸塩 | 12 | 4 | — | |
| Telmisartan / Hydrochlorothiazideテルミサルタン・ヒドロクロロチアジド | 12 | 6 | 9 | |
| Metoprolol Tartrateメトプロロール酒石酸塩 | 11 | 5 | — | |
| Temocapril Hydrochlorideテモカプリル塩酸塩 | 11 | 4 | 2 | |
| Betaxolol Hydrochlorideベタキソロール塩酸塩 | 9 | 4 | 2 | |
| Cilnidipineシルニジピン | 9 | 3 | 6 | |
| Alaceprilアラセプリル | 8 | 4 | 4 | |
| Candesartan Cilexetil / Hydrochlorothiazideカンデサルタンシレキセチル・ヒドロクロロチアジド | 6 | 3 | — | |
| Eplerenoneエプレレノン | 6 | 2 | — | |
| Esaxerenoneエサキセレノン | 6 | 1 | — | |
| Nilvadipineニルバジピン | 6 | 3 | — | |
| Bunazosin Hydrochlorideブナゾシン塩酸塩 | 5 | 2 | — | |
| Captoprilカプトプリル | 4 | 1 | 1 | |
| Celiprolol Hydrochlorideセリプロロール塩酸塩 | 4 | 2 | — | |
| Felodipineフェロジピン | 4 | 2 | — | |
| Labetalol Hydrochlorideラベタロール塩酸塩 | 4 | 2 | 1 | |
| Methyldopa Hydrateメチルドパ水和物 | 4 | 2 | — | |
| Perindopril Erbumineペリンドプリルエルブミン | 4 | 2 | — | |
| Terazosin Hydrochloride Hydrateテラゾシン塩酸塩水和物 | 4 | 1 | — | |
| Trandolaprilトランドラプリル | 4 | 2 | 1 | |
| Barnidipine Hydrochlorideバルニジピン塩酸塩 | 3 | 1 | — | |
| Bevantolol Hydrochlorideベバントロール塩酸塩 | 3 | 1 | 2 | |
| Bisoprololビソプロロール | 3 | 1 | — | |
| Delapril Hydrochlorideデラプリル塩酸塩 | 3 | 1 | — | |
| Efonidipine Hydrochloride Ethanolateエホニジピン塩酸塩エタノール付加物 | 3 | 1 | — | |
| Hydralazine Hydrochlorideヒドララジン塩酸塩 | 3 | 1 | 1 | |
| Clonidine Hydrochlorideクロニジン塩酸塩 | 2 | 1 | 2 | |
| Indapamideインダパミド | 2 | 1 | — | |
| Irbesartan / Trichlormethiazideイルベサルタン・トリクロルメチアジド | 2 | 1 | — | |
| Olmesartan Medoxomil / Azelnidipineオルメサルタンメドキソミル・アゼルニジピン | 2 | 1 | — | |
| Prazosin Hydrochlorideプラゾシン塩酸塩 | 2 | 1 | — | |
| Sodium Nitroprusside Hydrateニトロプルシドナトリウム水和物 | 2 | 1 | — | |
| Urapidilウラピジル | 2 | 1 | — | |
| Aliskiren Fumarateアリスキレンフマル酸塩 | 1 | 1 | 1 | |
| Amosulalol Hydrochlorideアモスラロール塩酸塩 | 1 | 1 | — | |
| Guanabenz Acetateグアナベンズ酢酸塩 | 1 | 1 | — | |
| Telmisartan / Amlodipine Besilate / Hydrochlorothiazideテルミサルタン・アムロジピンベシル酸塩・ヒドロクロロチアジド | 1 | 1 | — | |
| Valsartan / Cilnidipineバルサルタン・シルニジピン | 1 | 1 | — |
Products counts every marketed product across all strengths and forms, not companies. Companies is the number of companies marketing that molecule; the same company may appear under several molecules, so the column does not add up to a class total. Market size sits on each molecule's own page, valued at national price rather than transaction price. Figures are as at 2026-08-28.
Tell us which molecules matter to you. We will tell you what the public data can and cannot answer before you commission anything.
Send an enquiryOur Database Division replies in English within three business days (Japan time).
